Séjournet, L.; Kodjikian, L.; Elbany, S.; Allignet, B.; Agard, E.; Chaperon, M.; Billant, J.; Denis, P.; Mathis, T.; Burillon, C.;
et al. Focal Photocoagulation as an Adjunctive Therapy to Reduce the Burden of Intravitreal Injections in Macula Edema Patients, the LyoMAC2 Study. Pharmaceutics 2023, 15, 308.
https://doi.org/10.3390/pharmaceutics15020308
AMA Style
Séjournet L, Kodjikian L, Elbany S, Allignet B, Agard E, Chaperon M, Billant J, Denis P, Mathis T, Burillon C,
et al. Focal Photocoagulation as an Adjunctive Therapy to Reduce the Burden of Intravitreal Injections in Macula Edema Patients, the LyoMAC2 Study. Pharmaceutics. 2023; 15(2):308.
https://doi.org/10.3390/pharmaceutics15020308
Chicago/Turabian Style
Séjournet, Lucas, Laurent Kodjikian, Sandra Elbany, Benoit Allignet, Emilie Agard, Mayeul Chaperon, Jérémy Billant, Philippe Denis, Thibaud Mathis, Carole Burillon,
and et al. 2023. "Focal Photocoagulation as an Adjunctive Therapy to Reduce the Burden of Intravitreal Injections in Macula Edema Patients, the LyoMAC2 Study" Pharmaceutics 15, no. 2: 308.
https://doi.org/10.3390/pharmaceutics15020308
APA Style
Séjournet, L., Kodjikian, L., Elbany, S., Allignet, B., Agard, E., Chaperon, M., Billant, J., Denis, P., Mathis, T., Burillon, C., & Dot, C.
(2023). Focal Photocoagulation as an Adjunctive Therapy to Reduce the Burden of Intravitreal Injections in Macula Edema Patients, the LyoMAC2 Study. Pharmaceutics, 15(2), 308.
https://doi.org/10.3390/pharmaceutics15020308